Genome-wide associations of CD46 and IFI44L genetic variants with neutralizing antibody response to measles vaccine.
Genome-wide associations of CD46 and IFI44L genetic variants with neutralizing antibody response to measles vaccine.
复制标题
CD46 和 IFI44L 基因变异与麻疹疫苗中和抗体反应的全基因组关联。
DOI:
10.1007/s00439-017-1768-9
复制
发表时间:
2017-04
期刊:
影响因子:
5.3
通讯作者:
Poland GA
中科院分区:
文献类型:
--
作者:
Haralambieva IH;Ovsyannikova IG;Kennedy RB;Larrabee BR;Zimmermann MT;Grill DE;Schaid DJ;Poland GA
Population-based studies have revealed 2 to 10% measles vaccine failure rate even after two vaccine doses. While the mechanisms behind this remain unknown, we hypothesized that host genetic factors are likely to be involved. We performed a genome-wide association study of measles specific neutralizing antibody and IFNγ ELISPOT response in a combined sample of 2,872 subjects. We identified two distinct chromosome 1 regions (previously associated with MMR-related febrile seizures), associated with vaccine-induced measles neutralizing antibody titers. The 1q32 region contained 20 significant SNPs in/around the measles virus receptor-encoding CD46 gene, including the intronic rs2724384 (p-value = 2.64x10−09) and rs2724374 (p-value = 3.16x10−09) SNPs. The 1q31.1 region contained nine significant SNPs in/around IFI44L, including the intronic rs1333973 (p-value = 1.41x10−10) and the missense rs273259 (His73Arg, p-value = 2.87x10−10) SNPs. Analysis of differential exon usage with mRNA-Seq data and RT-PCR suggests the involvement of rs2724374 minor G allele in the CD46 STP region exon B skipping, resulting in shorter CD46 isoforms. Our study reveals common CD46 and IFI44L SNPs associated with measles-specific humoral immunity, and highlights the importance of alternative splicing/virus cellular receptor isoform usage as a mechanism explaining inter-individual variation in immune response after live measles vaccine.